Earnings Data
Report Date
Nov 04, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
―Last Year’s EPS
>-0.01Same Quarter Last Year
Based on 0 Analysts Ratings
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (BR:C2RS34) Earnings, Revenues Date & History
BR:C2RS34 Q2 2026 Earnings Report
BR:C2RS34 Upcoming Earnings
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
BR:C2RS34 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BR:C2RS34 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 03, 2026 | R$30.45 | R$33.48 | +9.95% |
May 04, 2026 | R$31.36 | R$30.73 | -2.01% |
Feb 12, 2026 | R$30.82 | R$34.95 | +13.40% |
Nov 10, 2025 | R$35.88 | R$36.48 | +1.67% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (BR:C2RS34) report earnings?
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (BR:C2RS34) is schdueled to report earning on Nov 04, 2026, After Close (Confirmed).
What is CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (BR:C2RS34) earnings time?
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (BR:C2RS34) earnings time is at Nov 04, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh stock?
The P/E ratio of CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh is N/A.
What is BR:C2RS34 EPS forecast?
Currently, no data Available